Clinical trial

Pentoxifylline and Progression of Chronic Kidney Disease in Moderate-to-high…

NCT00285298 · Walter Reed Army Medical Center, U.S. Fed · Completed

Key facts

NCT number NCT00285298
Title Pentoxifylline and Progression of Chronic Kidney Disease in Moderate-to-high Risk Patients
Official title Pentoxifylline and Progression of Chronic Kidney Disease in Moderate-to-high Risk Patients: a Pilot Randomized, Placebo-controlled, Double-blind Trial.
Lead sponsor Walter Reed Army Medical Center, U.S. Fed
Collaborators National Kidney Foundation, United States
Status Completed
Phase Phase 3
Study type Interventional
Conditions Kidney Failure, Chronic
Intervention type Drug
Interventions Pentoxifylline, Placebo
Enrollment 39
Start date Jan 1, 2006
Primary completion Apr 1, 2008
Completion Apr 1, 2008
First posted Feb 1, 2006
Last update posted Jul 29, 2011

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies